Bayer Aspirin Spec Campaign

Bayer Aspirin
Spec Campaign

Client: Bayer (Bayer AG)

Product: Aspirin (acetyl salicylic acid)

Audience: Healthcare Professionals (HCPs) – Primarily Primary Care Physicians (PCPs) & General Practitioners (GPs)

Campaign Strategy

The Challenge: To introduce Aspirin as a "new," first-in-class, FDA-approved therapy, for a clinical audience.

The Insight: HCPs are time-strapped and see patients with co-presenting symptoms. They need a single, reliable, first-line tool they can trust, not just disparate symptom relievers.

The Big Idea: We’re not selling a pill; we’re selling a pathway. We’re giving HCPs a new standard of care that targets the single biological source of their patients' three most common complaints.

  • Campaign Theme: The Trifecta of Relief

  • HCP Tagline: Pain. Fever. Inflammation. One Target.

  • Core Message: Aspirin is the first-in-class, FDA-approved COX inhibitor that provides a trifecta of relief (Analgesic, Antipyretic, Anti-inflammatory) by targeting one source: the prostaglandin pathway.

This campaign imagines that acetylsalicylic acid (aspirin) is a novel drug that just received FDA approval. Bayer has partnered with my fictional company, Nueva Group, to market the compound to healthcare providers.